Invitrogen™ LRRC17 Polyclonal Antibody

Rabbit Polyclonal Antibody

Supplier:  Invitrogen™ PA5139915

Catalog No. PIPA5139915

Description

Gently mix before use. Optimal concentrations and conditions for each application should be determined by the user. Immunogen sequence: DYNIHYLYYW LKHHYNVHFN GLECKTPEEY KGWSVGKYIR SYYEECPKDK LPAYPESFDQ DTEDDEWEKK HRDHTAKKQS VII.

Leucine-rich repeat-containing protein 17 (LRRC17) is an LRR protein predominantly expressed by osteoblasts. LRRC17 acts as a negative regulator of receptor activator of NF-kappaB ligand (RANKL)-induced osteoclast differentiation. It has been reported that low plasma level of LRRC17 is an independent risk factor for osteoporotic fractures.

Specifications

• Antigen: LRRC17
• Classification: Polyclonal
• Conjugate: Unconjugated
• Gene: LRRC17
• Gene Alias: 37 kDa leucine-rich repeat (LRR) protein; 37kDa; 4833425M04Rik; 6130400C22Rik; leucine rich repeat containing 17; leucine-rich repeat (LRR) protein; leucine-rich repeat-containing protein 17; Lrrc17; p37NB; UNQ3076/PRO9909
• Host Species: Rabbit
• Purification Method: Antigen affinity chromatography
• Regulatory Status: RUO
• Gene ID (Entrez): 10234
• Content And Storage: Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.
• Form: Liquid

• Applications: Immunocytochemistry
• Concentration: 0.1 mg/mL
• Formulation: PBS with 40% glycerol and 0.02% sodium azide; pH 7.2
• Gene Accession No.: Q8N6Y2
• Gene Symbols: LRRC17
• Immunogen: Recombinant protein corresponding to Human LRRC17. Recombinant protein control fragment (Product #RP-109345).
• Quantity: 100 μL
• Primary or Secondary: Primary
• Target Species: Human
• Product Type: Antibody
• Isotype: IgG

Safety and Handling

WARNING: Cancer - www.P65Warnings.ca.gov